BioCardia (BCDA)
BioCardia on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
678K
Short interest
settlement 2026-10-15
5.0
Days to cover
+3.8 days vs prior
60.0%
Short share of volume
2026-11-02
13,609
Fails to deliver
settlement 2026-10-08
Wed 11 Nov
Next earnings
estimated date
$11K
Insider flow, 90 days
7 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in BCDA is 678,398 shares, down 185,267 shares over the last month. Over the last 48 readings it ranged from 13,462 shares (13 June 2025) to 1,342,893 shares (15 July 2026). At the reported average volume of 134K shares a day that is 5.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bcda" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 678,398 | +9.6% | 134,256 | 5.05 |
| 2026-09-30 | 619,162 | -28.3% | 487,811 | 1.27 |
| 2026-09-15 | 863,665 | -14.3% | 187,434 | 4.61 |
| 2026-08-31 | 1,007,473 | -2.2% | 219,231 | 4.60 |
| 2026-08-14 | 1,029,782 | -7.0% | 298,017 | 3.46 |
| 2026-07-31 | 1,106,847 | -17.6% | 218,292 | 5.07 |
| 2026-07-15 | 1,342,893 | +261.2% | 509,766 | 2.63 |
| 2026-06-30 | 371,795 | -15.2% | 1,600,089 | 1.00 |
| 2026-06-15 | 438,565 | +33.1% | 14,585,069 | 1.00 |
| 2026-05-29 | 329,380 | +34.0% | 120,914 | 2.72 |
| 2026-05-15 | 245,775 | +48.2% | 551,652 | 1.00 |
| 2026-04-30 | 165,816 | -6.1% | 61,986 | 2.68 |
| 2026-04-15 | 176,560 | -0.4% | 63,543 | 2.78 |
| 2026-03-31 | 177,342 | -7.8% | 60,379 | 2.94 |
| 2026-03-13 | 192,257 | -11.8% | 75,675 | 2.54 |
| 2026-02-27 | 218,108 | -7.6% | 44,995 | 4.85 |
| 2026-02-13 | 236,144 | +1.1% | 84,016 | 2.81 |
| 2026-01-30 | 233,460 | +8.1% | 59,470 | 3.93 |
| 2026-01-15 | 216,070 | -13.4% | 71,577 | 3.02 |
| 2025-12-31 | 249,388 | +49.2% | 117,346 | 2.13 |
| 2025-12-15 | 167,154 | -9.7% | 64,416 | 2.59 |
| 2025-11-28 | 185,029 | +5.5% | 68,190 | 2.71 |
| 2025-11-14 | 175,318 | -16.8% | 73,264 | 2.39 |
| 2025-10-31 | 210,690 | -31.3% | 147,747 | 1.43 |
| 2025-10-15 | 306,467 | +54.1% | 365,265 | 1.00 |
| 2025-09-30 | 198,824 | +85.3% | 2,684,419 | 1.00 |
| 2025-09-15 | 107,303 | -48.8% | 41,396 | 2.59 |
| 2025-08-29 | 209,414 | -43.8% | 40,181 | 5.21 |
| 2025-08-15 | 372,812 | +319.7% | 1,133,010 | 1.00 |
| 2025-07-31 | 88,826 | -53.5% | 48,314 | 1.84 |
| 2025-07-15 | 191,112 | +821.0% | 416,062 | 1.00 |
| 2025-06-30 | 20,750 | +54.1% | 77,440 | 1.00 |
| 2025-06-13 | 13,462 | -41.6% | 30,197 | 1.00 |
| 2025-05-30 | 23,060 | -66.4% | 78,796 | 1.00 |
| 2025-05-15 | 68,607 | -49.9% | 80,826 | 1.00 |
| 2025-04-30 | 137,005 | +243.8% | 116,863 | 1.17 |
| 2025-04-15 | 39,850 | -24.6% | 52,494 | 1.00 |
| 2025-03-31 | 52,834 | +5.7% | 126,016 | 1.00 |
| 2025-03-14 | 49,965 | +111.0% | 51,279 | 1.00 |
| 2025-02-28 | 23,684 | -57.9% | 46,425 | 1.00 |
| 2025-02-14 | 56,218 | +4.7% | 54,983 | 1.02 |
| 2025-01-31 | 53,719 | +67.6% | 56,661 | 1.00 |
| 2025-01-15 | 32,049 | -36.4% | 39,457 | 1.00 |
| 2024-12-31 | 50,355 | -39.6% | 63,695 | 1.00 |
| 2024-12-13 | 83,357 | -19.5% | 31,354 | 2.66 |
| 2024-11-29 | 103,598 | -5.4% | 32,994 | 3.14 |
| 2024-11-15 | 109,483 | +26.9% | 57,036 | 1.92 |
| 2024-10-31 | 86,275 | +72.7% | 63,831 | 1.35 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of BCDA volume is 60.0%, up 15.6 points over the last five sessions. Over the last 30 readings it ranged from 14.1% (28 October 2026) to 84.5% (22 October 2026). The latest reading is 7.8 points above the 30-session average of 52.2%, on 50K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 30K | 50K | 60.0% | 0 |
| 2026-10-30 | 22K | 36K | 61.4% | 0 |
| 2026-10-29 | 4K | 14K | 25.4% | 0 |
| 2026-10-28 | 1K | 8K | 14.1% | 0 |
| 2026-10-27 | 9K | 13K | 67.0% | 0 |
| 2026-10-26 | 22K | 49K | 44.4% | 0 |
| 2026-10-23 | 15K | 23K | 66.3% | 90 |
| 2026-10-22 | 20K | 23K | 84.5% | 0 |
| 2026-10-21 | 30K | 102K | 29.0% | 3,170 |
| 2026-10-20 | 55K | 141K | 38.9% | 2 |
| 2026-10-19 | 146K | 194K | 75.4% | 580 |
| 2026-10-16 | 46K | 70K | 66.0% | 0 |
| 2026-10-15 | 82K | 123K | 66.4% | 0 |
| 2026-10-14 | 48K | 103K | 47.0% | 0 |
| 2026-10-13 | 33K | 51K | 63.9% | 8,500 |
| 2026-10-12 | 23K | 36K | 63.7% | 0 |
| 2026-10-09 | 20K | 60K | 33.6% | 0 |
| 2026-10-08 | 96K | 118K | 80.8% | 400 |
| 2026-10-07 | 94K | 143K | 65.6% | 1 |
| 2026-10-06 | 31K | 84K | 37.0% | 0 |
| 2026-10-05 | 18K | 58K | 31.1% | 0 |
| 2026-10-02 | 10K | 31K | 34.4% | 0 |
| 2026-10-01 | 61K | 104K | 58.5% | 0 |
| 2026-09-30 | 27K | 51K | 53.0% | 0 |
| 2026-09-29 | 25K | 63K | 39.1% | 5,894 |
| 2026-09-28 | 52K | 94K | 54.7% | 6,400 |
| 2026-09-25 | 10K | 23K | 42.2% | 0 |
| 2026-09-24 | 51K | 85K | 60.1% | 0 |
| 2026-09-23 | 38K | 84K | 45.6% | 0 |
| 2026-09-22 | 112K | 194K | 57.9% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 October 2026, the fails-to-deliver balance in BCDA is 13,609 shares, down 69,696 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (24 July 2026) to 97,035 shares (26 June 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-08 | 13,609 | $1.09 | $15K |
| 2026-09-23 | 83,305 | $1.05 | $87K |
| 2026-09-22 | 96,090 | $1.08 | $104K |
| 2026-09-21 | 10,178 | $1.17 | $12K |
| 2026-09-17 | 25,792 | $1.25 | $32K |
| 2026-09-15 | 15,830 | $1.19 | $19K |
| 2026-08-27 | 8,189 | $1.19 | $10K |
| 2026-08-25 | 460 | $1.06 | $488 |
| 2026-08-04 | 500 | $0.83 | $415 |
| 2026-08-03 | 8,453 | $0.82 | $7K |
| 2026-07-29 | 2,611 | $0.78 | $2K |
| 2026-07-28 | 5,030 | $0.81 | $4K |
| 2026-07-27 | 2,317 | $0.85 | $2K |
| 2026-07-24 | 1 | $0.91 | $1 |
| 2026-07-20 | 821 | $0.83 | $681 |
| 2026-07-13 | 307 | $0.91 | $279 |
| 2026-07-10 | 15,573 | $0.89 | $14K |
| 2026-07-08 | 6,851 | $1.02 | $7K |
| 2026-07-02 | 5,181 | $1.19 | $6K |
| 2026-06-30 | 9,063 | $1.21 | $11K |
| 2026-06-29 | 3,216 | $1.20 | $4K |
| 2026-06-26 | 97,035 | $1.09 | $106K |
| 2026-06-25 | 53,679 | $1.06 | $57K |
| 2026-06-24 | 210 | $1.00 | $210 |
| 2026-06-23 | 803 | $0.97 | $779 |
| 2026-06-22 | 4,725 | $0.97 | $5K |
| 2026-06-18 | 44 | $0.95 | $42 |
| 2026-06-17 | 11,531 | $0.87 | $10K |
| 2026-06-16 | 3,830 | $0.83 | $3K |
| 2026-06-12 | 590 | $0.80 | $472 |
Insider trades
SEC Form 4, newest first. JSONInsiders at BCDA reported 7 open-market buys worth $11K in the last 90 days and no open-market sells. Latest filing: Altman Peter (President and CEO) on 2026-10-16.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Altman Peter | President and CEO | Buy | 300 | $0.95 | $285 | 385K |
| 2026-10-15 | Altman Peter | President and CEO | Buy | 200 | $0.95 | $190 | 385K |
| 2026-09-29 | Altman Peter | President and CEO | Buy | 1K | $1.03 | $1K | 385K |
| 2026-09-23 | Altman Peter | President and CEO | Buy | 2K | $1.05 | $2K | 384K |
| 2026-09-03 | Altman Peter | President and CEO | Buy | 800 | $1.09 | $872 | 382K |
| 2026-08-17 | Altman Peter | President and CEO | Buy | 5K | $0.93 | $5K | 381K |
| 2026-08-13 | Altman Peter | President and CEO | Buy | 2K | $0.92 | $2K | 376K |
| 2026-07-29 | Altman Peter | President and CEO | Buy | 5K | $0.78 | $4K | 374K |
| 2026-07-17 | Altman Peter | President and CEO | Buy | 500 | $0.83 | $415 | 369K |
| 2026-07-15 | Altman Peter | President and CEO | Buy | 2K | $0.86 | $1K | 368K |
| 2026-07-14 | Altman Peter | President and CEO | Buy | 3K | $0.88 | $2K | 367K |
| 2026-07-10 | Altman Peter | President and CEO | Buy | 1K | $0.94 | $940 | 369K |
| 2026-07-09 | Altman Peter | President and CEO | Buy | 1K | $0.90 | $900 | 368K |
| 2026-07-08 | Altman Peter | President and CEO | Buy | 6K | $0.97 | $5K | 367K |
| 2026-07-08 | Altman Peter | President and CEO | Buy | 5K | $0.96 | $5K | 362K |
| 2026-07-02 | McClung David | Chief Financial Officer | Tax withholding | 23K | $1.24 | $29K | 114K |
| 2026-07-02 | GILLIS EDWARD M | Senior Vice President, Devices | Tax withholding | 17K | $1.24 | $21K | 54K |
| 2026-07-02 | Altman Peter | President and CEO | Tax withholding | 55K | $1.24 | $68K | 357K |
| 2026-06-29 | McClung David | Chief Financial Officer | Grant | 60K | $1.20 | $73K | 137K |
| 2026-06-29 | GILLIS EDWARD M | Senior Vice President, Devices | Grant | 40K | $1.20 | $47K | 71K |
| 2026-06-29 | Altman Peter | President and CEO | Grant | 111K | $1.20 | $133K | 411K |
| 2026-06-23 | STERTZER SIMON H | Director | Buy | 39K | $1.00 | $39K | 166K |
| 2026-06-22 | STERTZER SIMON H | Director | Buy | 70K | $0.92 | $65K | 127K |
| 2026-06-18 | Altman Peter | President and CEO | Buy | 800 | $0.96 | $768 | 301K |
| 2026-06-17 | Altman Peter | President and CEO | Buy | 2K | $0.85 | $1K | 300K |
| 2026-06-09 | Altman Peter | President and CEO | Buy | 5K | $0.85 | $4K | 298K |
| 2026-05-20 | Altman Peter | President and CEO | Buy | 2K | $0.92 | $1K | 293K |
| 2026-05-19 | Altman Peter | President and CEO | Buy | 200 | $0.95 | $190 | 292K |
| 2026-05-18 | Altman Peter | President and CEO | Buy | 6K | $0.92 | $5K | 292K |
| 2026-05-15 | Altman Peter | President and CEO | Buy | 5K | $1.02 | $5K | 286K |
| 2026-04-29 | Altman Peter | President and CEO | Buy | 5K | $1.11 | $6K | 281K |
| 2026-04-21 | Altman Peter | President and CEO | Buy | 400 | $1.23 | $492 | 276K |
| 2026-04-20 | Altman Peter | President and CEO | Buy | 600 | $1.23 | $738 | 275K |
| 2026-03-25 | Altman Peter | President and CEO | Buy | 300 | $1.22 | $366 | 275K |
| 2026-03-24 | Altman Peter | President and CEO | Buy | 600 | $1.24 | $744 | 274K |
| 2026-02-04 | Altman Peter | President and CEO | Buy | 5K | $1.13 | $6K | 274K |
| 2026-01-21 | Altman Peter | President and CEO | Buy | 300 | $1.34 | $402 | 269K |
| 2026-01-20 | Altman Peter | President and CEO | Buy | 600 | $1.32 | $792 | 269K |
| 2025-12-17 | Altman Peter | President and CEO | Buy | 900 | $1.30 | $1K | 268K |
| 2025-12-16 | Altman Peter | President and CEO | Buy | 200 | $1.37 | $274 | 267K |
| 2025-12-08 | McClung David | Chief Financial Officer | Tax withholding | 29K | $1.37 | $40K | 77K |
| 2025-12-08 | McClung David | Chief Financial Officer | Grant | 58K | $1.37 | $80K | 106K |
| 2025-12-08 | GILLIS EDWARD M | Senior Vice President, Devices | Tax withholding | 15K | $1.37 | $21K | 32K |
| 2025-12-08 | GILLIS EDWARD M | Senior Vice President, Devices | Grant | 38K | $1.37 | $52K | 47K |
| 2025-12-08 | Altman Peter | President and CEO | Tax withholding | 56K | $1.37 | $77K | 267K |
| 2025-12-08 | Altman Peter | President and CEO | Grant | 107K | $1.37 | $146K | 323K |
| 2025-09-19 | STERTZER SIMON H | Director | Buy | 398K | $1.25 | $498K | 591K |
| 2025-09-19 | Blank Andrew Scott | Director | Buy | 288K | $1.25 | $360K | 634K |
| 2025-09-19 | Altman Peter | President and CEO | Buy | 48K | $1.25 | $60K | 217K |
| 2025-08-22 | Altman Peter | President and CEO | Buy | 700 | $1.83 | $1K | 169K |
| 2025-08-13 | Altman Peter | President and CEO | Buy | 100 | $1.83 | $183 | 168K |
| 2025-08-12 | Altman Peter | President and CEO | Buy | 400 | $1.75 | $700 | 168K |
| 2025-08-11 | Altman Peter | President and CEO | Buy | 2K | $1.76 | $3K | 168K |
| 2025-06-30 | McClung David | Chief Financial Officer | Buy | 5K | $2.08 | $10K | 48K |
| 2025-06-30 | STERTZER SIMON H | Director | Buy | 72K | $2.08 | $150K | 193K |
| 2025-06-30 | Blank Andrew Scott | Director | Buy | 72K | $2.08 | $150K | 346K |
| 2025-06-30 | Altman Peter | President and CEO | Buy | 24K | $2.08 | $50K | 166K |
| 2025-05-30 | Altman Peter | President and CEO | Buy | 100 | $2.21 | $221 | 142K |
| 2025-05-22 | Altman Peter | President and CEO | Buy | 700 | $1.89 | $1K | 142K |
| 2025-05-20 | Altman Peter | President and CEO | Buy | 2K | $2.08 | $3K | 141K |
| 2025-05-16 | Altman Peter | President and CEO | Buy | 300 | $2.43 | $729 | 139K |
| 2025-05-14 | Altman Peter | President and CEO | Buy | 100 | $2.99 | $299 | 139K |
| 2025-04-23 | Altman Peter | President and CEO | Buy | 26K | $1.91 | $50K | 139K |
| 2025-04-23 | STERTZER SIMON H | Director | Buy | 105K | $1.91 | $201K | 120K |
| 2025-04-23 | Blank Andrew Scott | Director | Buy | 131K | $1.91 | $251K | 266K |
| 2025-04-23 | Facteau Bill | Director | Buy | 13K | $1.91 | $25K | 13K |
| 2025-04-23 | McClung David | Chief Financial Officer | Buy | 13K | $1.91 | $25K | 43K |
| 2025-04-23 | KRASNO RICHARD M | Director | Buy | 13K | $1.91 | $25K | 16K |
| 2025-04-15 | Altman Peter | President and CEO | Buy | 100 | $2.14 | $214 | 113K |
| 2025-04-11 | Altman Peter | President and CEO | Buy | 300 | $2.03 | $609 | 113K |
| 2025-04-10 | Altman Peter | President and CEO | Buy | 300 | $1.99 | $597 | 112K |
| 2025-04-07 | Altman Peter | President and CEO | Buy | 500 | $1.96 | $980 | 112K |
| 2025-04-04 | Altman Peter | President and CEO | Buy | 800 | $2.04 | $2K | 112K |
| 2025-04-03 | Altman Peter | President and CEO | Buy | 1K | $2.24 | $3K | 110K |
| 2025-04-03 | Altman Peter | President and CEO | Buy | 600 | $2.20 | $1K | 111K |
| 2025-04-02 | Altman Peter | President and CEO | Buy | 500 | $2.23 | $1K | 110K |
| 2025-03-05 | STERTZER SIMON H | Director | Buy | 1K | $2.45 | $2K | 57K |
| 2025-03-04 | STERTZER SIMON H | Director | Buy | 16K | $2.30 | $36K | 56K |
| 2025-03-03 | Altman Peter | President and CEO | Buy | 500 | $2.11 | $1K | 108K |
| 2025-03-03 | STERTZER SIMON H | Director | Buy | 23K | $2.30 | $52K | 41K |
| 2025-02-07 | Altman Peter | President and CEO | Buy | 600 | $2.48 | $1K | 108K |
| 2025-01-30 | Altman Peter | President and CEO | Buy | 239 | $2.38 | $569 | 107K |
| 2025-01-29 | Altman Peter | President and CEO | Buy | 500 | $2.40 | $1K | 107K |
| 2024-12-23 | Altman Peter | President and CEO | Buy | 1K | $2.06 | $2K | 107K |
| 2024-12-20 | GILLIS EDWARD M | Senior Vice President, Devices | Sell | 3K | $2.00 | $7K | 9K |
| 2024-12-05 | Altman Peter | President and CEO | Buy | 250 | $2.22 | $555 | 106K |
| 2024-11-15 | Altman Peter | President and CEO | Buy | 1K | $1.87 | $3K | 105K |
| 2024-10-11 | McClung David | Chief Financial Officer | Grant | 24K | $2.65 | $64K | 42K |
| 2024-10-11 | McClung David | Chief Financial Officer | Tax withholding | 12K | $2.65 | $31K | 30K |
| 2024-10-11 | Altman Peter | President and CEO | Tax withholding | 22K | $2.65 | $57K | 104K |
| 2024-10-11 | Altman Peter | President and CEO | Grant | 44K | $2.65 | $117K | 126K |
| 2024-10-11 | GILLIS EDWARD M | Senior Vice President, Devices | Grant | 16K | $2.65 | $42K | 19K |
| 2024-10-11 | GILLIS EDWARD M | Senior Vice President, Devices | Tax withholding | 7K | $2.65 | $18K | 12K |
| 2024-09-03 | Allen Jim L. | Director | Grant | 50K | $3.00 | $150K | 110K |
| 2024-09-03 | Altman Peter | President and CEO | Grant | 42K | $3.00 | $125K | 81K |
| 2024-09-03 | Blank Andrew Scott | Director | Grant | 111K | $3.00 | $333K | 135K |
| 2024-09-03 | McClung David | Chief Financial Officer | Grant | 8K | $3.00 | $25K | 17K |
| 2024-07-01 | Altman Peter | President and CEO | Buy | 300 | $3.05 | $915 | 40K |
| 2024-06-28 | Altman Peter | President and CEO | Buy | 200 | $2.99 | $598 | 39K |
| 2024-06-21 | Altman Peter | President and CEO | Buy | 500 | $3.29 | $2K | 39K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of BCDA in its latest filing, on Schedule 13G (passive). The holder is Lincoln Alternative Strategies LLC at 7.5% of the class (800,000 shares), filed 2025-09-19 for an event on 2025-09-19.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2025-09-24 | 13G | Mitchell P. Kopinparent holding company, individual | 557K | 5.0% | 2025-09-18 |
| 2025-09-24 | 13G | Daniel B. Asherparent holding company, individual | 557K | 5.0% | 2025-09-18 |
| 2025-09-24 | 13G | INTRACOASTAL CAPITAL, LLCother entity | 557K | 5.0% | 2025-09-18 |
| 2025-09-19 | 13G | Lincoln Alternative Strategies LLCother entity | 800K | 7.5% | 2025-09-19 |
13F holders
Tracked managers holding BCDA at their latest 13F. JSON1 of the 30 tracked managers held BCDA at their latest 13F, $28K in total at quarter-end prices. Citadel Advisors is the largest at $28K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 23K | $28K | 0.00% | -40K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
BioCardia in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows BioCardia (BCDA), SEC CIK 925741, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2025-09-24.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-16.JSON and CSV
- Company record
- EDGAR filing index for CIK 925741Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of BCDA is sold short?
678,398 shares were held short at the 2026-10-15 settlement, 5.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BCDA's daily short volume?
On 2026-11-02, 30,074 of the 50,123 BCDA shares reported to FINRA were sold short, 60.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BCDA have fails to deliver?
The SEC's latest file shows 13,609 BCDA shares failed to deliver at settlement 2026-10-08. Fails are reported per settlement date and published twice a month with a lag.
Are BCDA insiders buying or selling?
Insiders at BCDA reported 7 open-market buys worth $11K in the last 90 days and no open-market sells. Latest filing: Altman Peter (President and CEO) on 2026-10-16.
Who owns 5% or more of BCDA?
1 holder reports 5% or more of BCDA in its latest filing, on Schedule 13G (passive). The holder is Lincoln Alternative Strategies LLC at 7.5% of the class (800,000 shares), filed 2025-09-19 for an event on 2025-09-19.
Which tracked 13F managers own BCDA?
1 of the 30 tracked 13F managers held BCDA shares at their latest filing, $28K in all. The largest: Ken Griffin's Citadel Advisors (23K shares, $28K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.